Reynolds, Vincent L.
Eli Lilly (United States)
2 papers on CoChat
Most cited papers
- Verified
LY2405319, an engineered FGF21 variant, improves the metabolic status of diabetic monkeys
Adams, A. C., Halstead, C. A., Hansen, B. C., Irizarry, A. R., Martin, J. A., Myers, S. R., Reynolds, V. L., Smith, H. W., Wroblewski, V. J., & Kharitonenkov, A. (2013) · PLoS ONE
Fibroblast Growth Factor ResearchAdipokines, Inflammation, and Metabolic Diseases
Cited by 169
- Verified
Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonist
Benichou, O., Coskun, T., Gonciarz, M. D., Garhyan, P., Adams, A. C., Du, Y., Dunbar, J. D., Martin, J. A., Mather, K. J., Pickard, R. T., et al. (2023) · Cell Metabolism
Regulation of Appetite and ObesityGDF15 and Related Biomarkers
Cited by 115
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free